Qiang Fu
Concepts (455)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Flatfishes | 2 | 2022 | 2 | 1.770 |
Why?
| Fish Diseases | 2 | 2022 | 5 | 1.760 |
Why?
| Osteoblasts | 7 | 2017 | 514 | 1.720 |
Why?
| Osteoarthritis | 2 | 2023 | 71 | 1.700 |
Why?
| Hearing | 2 | 2020 | 61 | 1.490 |
Why?
| Bone Resorption | 5 | 2023 | 326 | 1.410 |
Why?
| Animals | 49 | 2023 | 14385 | 1.380 |
Why?
| Vitamin E | 6 | 2020 | 107 | 1.330 |
Why?
| Cochlear Implants | 3 | 2020 | 58 | 1.320 |
Why?
| Chromans | 5 | 2014 | 62 | 1.210 |
Why?
| Osteoclasts | 7 | 2023 | 469 | 1.200 |
Why?
| RANK Ligand | 10 | 2017 | 183 | 1.190 |
Why?
| Radiation-Protective Agents | 7 | 2020 | 116 | 1.150 |
Why?
| Cell-Derived Microparticles | 2 | 2017 | 21 | 1.120 |
Why?
| Mice | 35 | 2023 | 6413 | 1.010 |
Why?
| Brachyura | 1 | 2023 | 1 | 0.960 |
Why?
| Phenanthrenes | 1 | 2023 | 13 | 0.960 |
Why?
| Soil Pollutants | 1 | 2023 | 11 | 0.950 |
Why?
| Hemiptera | 1 | 2023 | 3 | 0.940 |
Why?
| Insecticides | 1 | 2023 | 19 | 0.930 |
Why?
| Cartilage, Articular | 1 | 2023 | 50 | 0.910 |
Why?
| Vibrio Infections | 1 | 2022 | 2 | 0.890 |
Why?
| Vibrio | 1 | 2022 | 5 | 0.890 |
Why?
| NF-kappa B | 2 | 2022 | 335 | 0.890 |
Why?
| Aeromonas salmonicida | 1 | 2022 | 3 | 0.880 |
Why?
| Perciformes | 1 | 2022 | 3 | 0.880 |
Why?
| Acoustics | 2 | 2020 | 38 | 0.880 |
Why?
| Carrier Proteins | 5 | 2015 | 359 | 0.880 |
Why?
| Erectile Dysfunction | 1 | 2023 | 83 | 0.840 |
Why?
| Osteocytes | 2 | 2023 | 220 | 0.820 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2023 | 140 | 0.810 |
Why?
| Paclitaxel | 2 | 2019 | 103 | 0.800 |
Why?
| Ear | 1 | 2020 | 21 | 0.780 |
Why?
| Auditory Cortex | 1 | 2020 | 22 | 0.770 |
Why?
| Noise | 1 | 2020 | 38 | 0.760 |
Why?
| Somatostatin | 2 | 2011 | 26 | 0.750 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 150 | 0.730 |
Why?
| Intestines | 7 | 2022 | 204 | 0.710 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2019 | 87 | 0.680 |
Why?
| NF-E2-Related Factor 2 | 3 | 2023 | 63 | 0.640 |
Why?
| Phosphatidylinositol 3-Kinases | 3 | 2023 | 153 | 0.630 |
Why?
| Imipramine | 1 | 2017 | 16 | 0.610 |
Why?
| Whole-Body Irradiation | 7 | 2021 | 160 | 0.600 |
Why?
| Gene Expression Regulation | 7 | 2022 | 1062 | 0.600 |
Why?
| Osteoporosis, Postmenopausal | 1 | 2017 | 36 | 0.590 |
Why?
| Speech Perception | 2 | 2015 | 90 | 0.590 |
Why?
| Bone Density Conservation Agents | 1 | 2017 | 83 | 0.560 |
Why?
| Intestinal Mucosa | 5 | 2021 | 259 | 0.560 |
Why?
| Radiation Injuries, Experimental | 3 | 2019 | 105 | 0.560 |
Why?
| Bone Remodeling | 2 | 2015 | 177 | 0.540 |
Why?
| Subcellular Fractions | 1 | 2015 | 43 | 0.540 |
Why?
| Pitch Perception | 1 | 2015 | 11 | 0.530 |
Why?
| Oxidative Stress | 7 | 2023 | 958 | 0.520 |
Why?
| Rats | 6 | 2023 | 3415 | 0.520 |
Why?
| Auditory Threshold | 1 | 2015 | 47 | 0.510 |
Why?
| Cell Communication | 1 | 2015 | 72 | 0.510 |
Why?
| Humans | 39 | 2024 | 54284 | 0.510 |
Why?
| Mevalonic Acid | 1 | 2014 | 7 | 0.500 |
Why?
| Tobacco, Smokeless | 1 | 2014 | 28 | 0.500 |
Why?
| RNA, Messenger | 9 | 2022 | 1202 | 0.500 |
Why?
| Deafness | 1 | 2015 | 33 | 0.500 |
Why?
| Emulsions | 1 | 2014 | 27 | 0.490 |
Why?
| Hearing Aids | 1 | 2015 | 63 | 0.490 |
Why?
| Inflammation | 4 | 2023 | 674 | 0.490 |
Why?
| Enhancer Elements, Genetic | 3 | 2011 | 64 | 0.460 |
Why?
| Mice, Inbred C57BL | 12 | 2022 | 1999 | 0.460 |
Why?
| Transcription Factors | 3 | 2022 | 622 | 0.450 |
Why?
| Chondrocytes | 2 | 2023 | 37 | 0.450 |
Why?
| Endothelium, Vascular | 4 | 2010 | 288 | 0.450 |
Why?
| Fish Proteins | 2 | 2022 | 5 | 0.440 |
Why?
| Pancreas | 2 | 2011 | 80 | 0.440 |
Why?
| Hydrogen Peroxide | 2 | 2023 | 142 | 0.440 |
Why?
| Neoplasms | 3 | 2019 | 1316 | 0.430 |
Why?
| Interleukin-1beta | 2 | 2023 | 92 | 0.430 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 176 | 0.420 |
Why?
| Up-Regulation | 2 | 2015 | 508 | 0.400 |
Why?
| Radiation, Ionizing | 4 | 2022 | 120 | 0.390 |
Why?
| Acoustic Stimulation | 2 | 2020 | 99 | 0.380 |
Why?
| Cell Line | 5 | 2017 | 1153 | 0.370 |
Why?
| Pancreatic Neoplasms | 2 | 2023 | 234 | 0.370 |
Why?
| Osteoprotegerin | 2 | 2023 | 57 | 0.350 |
Why?
| Thrombomodulin | 2 | 2008 | 41 | 0.340 |
Why?
| Parathyroid Hormone | 6 | 2017 | 196 | 0.340 |
Why?
| Gene Expression Profiling | 4 | 2022 | 1138 | 0.330 |
Why?
| Membrane Glycoproteins | 3 | 2006 | 269 | 0.330 |
Why?
| Sepsis | 2 | 2023 | 251 | 0.330 |
Why?
| Cytokines | 4 | 2023 | 676 | 0.320 |
Why?
| Female | 21 | 2023 | 28441 | 0.320 |
Why?
| Bone Substitutes | 1 | 2007 | 12 | 0.310 |
Why?
| Smoking Cessation | 2 | 2023 | 316 | 0.310 |
Why?
| Ceramics | 1 | 2007 | 10 | 0.310 |
Why?
| Male | 22 | 2023 | 27334 | 0.300 |
Why?
| Teriparatide | 1 | 2006 | 14 | 0.290 |
Why?
| Immunity, Innate | 2 | 2022 | 114 | 0.290 |
Why?
| Jejunum | 2 | 2021 | 56 | 0.280 |
Why?
| Arthroscopy | 2 | 2023 | 57 | 0.270 |
Why?
| Models, Biological | 4 | 2019 | 823 | 0.270 |
Why?
| Wound Healing | 2 | 2023 | 228 | 0.270 |
Why?
| Hip Joint | 2 | 2023 | 66 | 0.270 |
Why?
| DNA-Binding Proteins | 1 | 2008 | 462 | 0.260 |
Why?
| Coculture Techniques | 2 | 2023 | 160 | 0.260 |
Why?
| Intestine, Small | 2 | 2021 | 123 | 0.260 |
Why?
| Interleukin-6 | 2 | 2022 | 315 | 0.250 |
Why?
| Biodegradation, Environmental | 1 | 2023 | 10 | 0.240 |
Why?
| Pseudomonas | 1 | 2023 | 11 | 0.240 |
Why?
| Pneumoperitoneum | 1 | 2023 | 4 | 0.240 |
Why?
| Soil Microbiology | 1 | 2023 | 23 | 0.240 |
Why?
| Pulmonary Atelectasis | 1 | 2023 | 12 | 0.240 |
Why?
| Soil | 1 | 2023 | 26 | 0.240 |
Why?
| Radiation Injuries | 4 | 2010 | 153 | 0.240 |
Why?
| Bioprinting | 1 | 2023 | 1 | 0.240 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2023 | 434 | 0.230 |
Why?
| B-Lymphocytes, Regulatory | 1 | 2023 | 2 | 0.230 |
Why?
| Arabidopsis Proteins | 1 | 2023 | 31 | 0.230 |
Why?
| Femoracetabular Impingement | 1 | 2023 | 8 | 0.230 |
Why?
| Medicine, Chinese Traditional | 1 | 2023 | 8 | 0.230 |
Why?
| Hyperglycemia | 1 | 2023 | 84 | 0.230 |
Why?
| Soft Tissue Injuries | 1 | 2023 | 22 | 0.230 |
Why?
| Communicable Diseases | 1 | 2024 | 58 | 0.230 |
Why?
| Penile Erection | 1 | 2023 | 23 | 0.230 |
Why?
| Primary Ovarian Insufficiency | 1 | 2022 | 4 | 0.220 |
Why?
| Soft Tissue Neoplasms | 1 | 2023 | 65 | 0.220 |
Why?
| Cross Infection | 1 | 2024 | 107 | 0.220 |
Why?
| Receptors, Cytokine | 1 | 2022 | 13 | 0.220 |
Why?
| Organ Transplantation | 1 | 2023 | 48 | 0.220 |
Why?
| Caffeic Acids | 1 | 2022 | 5 | 0.220 |
Why?
| Cathepsins | 1 | 2022 | 8 | 0.220 |
Why?
| Succinates | 1 | 2022 | 4 | 0.220 |
Why?
| Spine | 2 | 2022 | 111 | 0.220 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2022 | 19 | 0.220 |
Why?
| Immunoglobulin A | 1 | 2022 | 54 | 0.220 |
Why?
| Smoking | 2 | 2019 | 556 | 0.220 |
Why?
| Fishes | 1 | 2022 | 26 | 0.220 |
Why?
| Penis | 1 | 2023 | 84 | 0.210 |
Why?
| Lysosomal-Associated Membrane Protein 2 | 1 | 2022 | 5 | 0.210 |
Why?
| Protein Isoforms | 1 | 2022 | 124 | 0.210 |
Why?
| Cells, Cultured | 5 | 2017 | 1737 | 0.210 |
Why?
| Counseling | 2 | 2023 | 149 | 0.210 |
Why?
| Amino Acid Sequence | 2 | 2022 | 767 | 0.210 |
Why?
| Anti-Arrhythmia Agents | 1 | 2022 | 87 | 0.210 |
Why?
| Water | 1 | 2022 | 102 | 0.210 |
Why?
| Bone Diseases | 1 | 2023 | 109 | 0.210 |
Why?
| Molecular Chaperones | 1 | 2022 | 64 | 0.210 |
Why?
| Tissue Distribution | 2 | 2019 | 178 | 0.200 |
Why?
| Duodenum | 1 | 2021 | 36 | 0.200 |
Why?
| Phylogeny | 1 | 2022 | 269 | 0.200 |
Why?
| Nanoparticles | 2 | 2013 | 173 | 0.200 |
Why?
| Cell Differentiation | 3 | 2017 | 720 | 0.200 |
Why?
| Ileum | 1 | 2021 | 102 | 0.190 |
Why?
| Anti-Inflammatory Agents | 1 | 2022 | 175 | 0.190 |
Why?
| Health Behavior | 2 | 2023 | 277 | 0.190 |
Why?
| Vocabulary | 1 | 2020 | 18 | 0.190 |
Why?
| Signal-To-Noise Ratio | 1 | 2020 | 23 | 0.190 |
Why?
| Apoptosis | 3 | 2022 | 1300 | 0.190 |
Why?
| Thrombosis | 1 | 2023 | 243 | 0.190 |
Why?
| Auditory Perception | 1 | 2020 | 29 | 0.190 |
Why?
| Electric Stimulation | 1 | 2020 | 95 | 0.190 |
Why?
| Reperfusion Injury | 1 | 2021 | 118 | 0.190 |
Why?
| Uterine Cervical Neoplasms | 1 | 2023 | 276 | 0.190 |
Why?
| Statistics as Topic | 1 | 2020 | 103 | 0.190 |
Why?
| Evoked Potentials, Auditory | 1 | 2020 | 98 | 0.190 |
Why?
| Drug Administration Schedule | 2 | 2019 | 401 | 0.180 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2020 | 69 | 0.180 |
Why?
| Rats, Sprague-Dawley | 2 | 2023 | 1663 | 0.180 |
Why?
| Autophagy | 1 | 2022 | 202 | 0.180 |
Why?
| Transcriptome | 1 | 2022 | 346 | 0.180 |
Why?
| Diabetes Mellitus | 1 | 2023 | 309 | 0.180 |
Why?
| Atrial Fibrillation | 1 | 2022 | 197 | 0.180 |
Why?
| Liver Transplantation | 1 | 2021 | 160 | 0.180 |
Why?
| Adult | 5 | 2023 | 14207 | 0.180 |
Why?
| Mitochondria | 2 | 2022 | 489 | 0.180 |
Why?
| Pregnancy, Unwanted | 1 | 2019 | 5 | 0.180 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2019 | 25 | 0.180 |
Why?
| Pregnancy, Unplanned | 1 | 2019 | 6 | 0.180 |
Why?
| Contraception Behavior | 1 | 2019 | 12 | 0.170 |
Why?
| Mice, Knockout | 5 | 2022 | 926 | 0.170 |
Why?
| Infusions, Intravenous | 1 | 2019 | 231 | 0.170 |
Why?
| Patient Navigation | 1 | 2019 | 13 | 0.170 |
Why?
| Adenocarcinoma | 1 | 2023 | 428 | 0.170 |
Why?
| Heptanoic Acids | 2 | 2008 | 39 | 0.170 |
Why?
| Hyperparathyroidism | 2 | 2011 | 50 | 0.160 |
Why?
| Signal Transduction | 2 | 2022 | 1753 | 0.160 |
Why?
| Reproducibility of Results | 1 | 2022 | 1304 | 0.160 |
Why?
| Pyrroles | 2 | 2008 | 78 | 0.160 |
Why?
| Gene Expression | 4 | 2013 | 664 | 0.150 |
Why?
| Lung Neoplasms | 1 | 2023 | 642 | 0.150 |
Why?
| Macrophages | 2 | 2023 | 405 | 0.140 |
Why?
| Chemokines | 2 | 2019 | 96 | 0.140 |
Why?
| Radiotherapy | 2 | 2007 | 138 | 0.140 |
Why?
| Perceptual Masking | 1 | 2015 | 12 | 0.130 |
Why?
| Random Allocation | 3 | 2013 | 312 | 0.130 |
Why?
| Music | 1 | 2015 | 7 | 0.130 |
Why?
| Membrane Transport Proteins | 1 | 2015 | 57 | 0.130 |
Why?
| Microscopy, Electron, Transmission | 1 | 2015 | 87 | 0.130 |
Why?
| Blotting, Western | 2 | 2015 | 683 | 0.130 |
Why?
| Heat-Shock Proteins | 1 | 2015 | 87 | 0.130 |
Why?
| Tissue Engineering | 2 | 2023 | 61 | 0.130 |
Why?
| Microscopy, Confocal | 1 | 2015 | 110 | 0.130 |
Why?
| Flow Cytometry | 2 | 2015 | 546 | 0.130 |
Why?
| RNA, Small Interfering | 2 | 2013 | 252 | 0.130 |
Why?
| Confidence Intervals | 1 | 2014 | 167 | 0.130 |
Why?
| Demography | 1 | 2014 | 99 | 0.120 |
Why?
| Dose-Response Relationship, Radiation | 3 | 2010 | 204 | 0.120 |
Why?
| Injections, Subcutaneous | 1 | 2014 | 58 | 0.120 |
Why?
| Ovariectomy | 1 | 2014 | 125 | 0.120 |
Why?
| Cochlear Implantation | 1 | 2015 | 70 | 0.120 |
Why?
| Breast Neoplasms | 1 | 2023 | 1248 | 0.120 |
Why?
| Intestinal Diseases | 2 | 2019 | 36 | 0.120 |
Why?
| Middle Aged | 4 | 2023 | 13088 | 0.120 |
Why?
| Polyethylene Glycols | 1 | 2014 | 106 | 0.120 |
Why?
| Interleukin-2 | 1 | 2013 | 75 | 0.120 |
Why?
| Memory, Short-Term | 1 | 2014 | 85 | 0.120 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2013 | 75 | 0.120 |
Why?
| Interleukin-10 | 1 | 2014 | 107 | 0.120 |
Why?
| Databases, Genetic | 1 | 2013 | 101 | 0.110 |
Why?
| Quaternary Ammonium Compounds | 1 | 2013 | 24 | 0.110 |
Why?
| Gene Transfer Techniques | 1 | 2013 | 41 | 0.110 |
Why?
| Chitosan | 1 | 2013 | 34 | 0.110 |
Why?
| Adipocytes | 1 | 2014 | 129 | 0.110 |
Why?
| Odds Ratio | 1 | 2014 | 604 | 0.110 |
Why?
| Dose-Response Relationship, Drug | 2 | 2020 | 1476 | 0.110 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2014 | 377 | 0.110 |
Why?
| Core Binding Factor Alpha 1 Subunit | 3 | 2009 | 48 | 0.110 |
Why?
| Aged | 3 | 2015 | 10054 | 0.110 |
Why?
| Cancer Vaccines | 1 | 2013 | 103 | 0.110 |
Why?
| Bone Demineralization, Pathologic | 1 | 2011 | 5 | 0.110 |
Why?
| Protein Binding | 3 | 2013 | 736 | 0.110 |
Why?
| Adipose Tissue | 1 | 2014 | 207 | 0.110 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 3 | 2006 | 32 | 0.100 |
Why?
| Lactation | 1 | 2011 | 61 | 0.100 |
Why?
| Trypsin | 1 | 2011 | 17 | 0.100 |
Why?
| Bone Density | 3 | 2011 | 416 | 0.100 |
Why?
| Bacteria | 1 | 2013 | 258 | 0.100 |
Why?
| Prevalence | 1 | 2014 | 1025 | 0.100 |
Why?
| Ultrasonography | 2 | 2023 | 480 | 0.100 |
Why?
| Drug Delivery Systems | 1 | 2013 | 151 | 0.100 |
Why?
| Immunotherapy | 1 | 2013 | 263 | 0.100 |
Why?
| Pentoxifylline | 1 | 2010 | 19 | 0.100 |
Why?
| Hematopoiesis | 1 | 2010 | 80 | 0.090 |
Why?
| Young Adult | 1 | 2020 | 4318 | 0.090 |
Why?
| Blood Vessels | 1 | 2010 | 78 | 0.090 |
Why?
| Interferon-gamma | 1 | 2011 | 195 | 0.090 |
Why?
| Radiation Dosage | 3 | 2021 | 170 | 0.090 |
Why?
| Leukocytes | 1 | 2010 | 85 | 0.090 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 151 | 0.090 |
Why?
| Mental Disorders | 1 | 2014 | 451 | 0.090 |
Why?
| Cesium Radioisotopes | 1 | 2009 | 5 | 0.090 |
Why?
| Thermoluminescent Dosimetry | 1 | 2009 | 7 | 0.090 |
Why?
| Chemokine CXCL9 | 1 | 2009 | 10 | 0.090 |
Why?
| Bacterial Translocation | 1 | 2009 | 23 | 0.090 |
Why?
| Hydroxymethylglutaryl CoA Reductases | 1 | 2009 | 10 | 0.090 |
Why?
| Poverty | 2 | 2023 | 231 | 0.090 |
Why?
| Cyclic AMP Response Element-Binding Protein | 2 | 2006 | 34 | 0.090 |
Why?
| Interleukin-12 | 1 | 2009 | 37 | 0.090 |
Why?
| Blood Cells | 1 | 2009 | 58 | 0.090 |
Why?
| Cerebellum | 1 | 2010 | 142 | 0.090 |
Why?
| Cell Lineage | 1 | 2009 | 93 | 0.080 |
Why?
| rho-Associated Kinases | 1 | 2008 | 20 | 0.080 |
Why?
| Citrulline | 1 | 2009 | 98 | 0.080 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 9 | 0.080 |
Why?
| Time Factors | 3 | 2011 | 3213 | 0.080 |
Why?
| Sp1 Transcription Factor | 1 | 2008 | 18 | 0.080 |
Why?
| 14-3-3 Proteins | 1 | 2008 | 24 | 0.080 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2008 | 40 | 0.080 |
Why?
| Brain Injuries | 1 | 2010 | 183 | 0.080 |
Why?
| HSP90 Heat-Shock Proteins | 1 | 2008 | 53 | 0.080 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2023 | 596 | 0.080 |
Why?
| Enzyme Inhibitors | 1 | 2010 | 446 | 0.080 |
Why?
| X-Ray Diffraction | 1 | 2007 | 21 | 0.080 |
Why?
| MAP Kinase Signaling System | 1 | 2008 | 133 | 0.080 |
Why?
| Kaplan-Meier Estimate | 1 | 2009 | 514 | 0.080 |
Why?
| 3T3 Cells | 1 | 2007 | 52 | 0.080 |
Why?
| Microscopy, Electron, Scanning | 1 | 2007 | 52 | 0.080 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 117 | 0.080 |
Why?
| Cell Proliferation | 2 | 2013 | 1096 | 0.080 |
Why?
| Simvastatin | 1 | 2007 | 35 | 0.080 |
Why?
| Peroxynitrous Acid | 3 | 2013 | 51 | 0.080 |
Why?
| Hypolipidemic Agents | 1 | 2007 | 33 | 0.080 |
Why?
| Materials Testing | 1 | 2007 | 62 | 0.080 |
Why?
| Tissue Plasminogen Activator | 1 | 2008 | 124 | 0.080 |
Why?
| Alkaline Phosphatase | 1 | 2007 | 99 | 0.070 |
Why?
| Connective Tissue | 1 | 2006 | 23 | 0.070 |
Why?
| Glutathione | 2 | 2022 | 330 | 0.070 |
Why?
| Transcription Initiation Site | 1 | 2006 | 13 | 0.070 |
Why?
| Treatment Outcome | 3 | 2022 | 5604 | 0.070 |
Why?
| Protein Kinase Inhibitors | 1 | 2008 | 216 | 0.070 |
Why?
| Base Pairing | 1 | 2006 | 28 | 0.070 |
Why?
| Conserved Sequence | 1 | 2006 | 57 | 0.070 |
Why?
| C-Reactive Protein | 1 | 2007 | 159 | 0.070 |
Why?
| Cyclic AMP | 1 | 2006 | 106 | 0.070 |
Why?
| Gene Deletion | 1 | 2007 | 293 | 0.070 |
Why?
| Organ Specificity | 1 | 2006 | 126 | 0.070 |
Why?
| Cattle | 1 | 2006 | 224 | 0.070 |
Why?
| Adolescent | 2 | 2014 | 6897 | 0.070 |
Why?
| Binding Sites | 1 | 2006 | 440 | 0.070 |
Why?
| Cell Survival | 1 | 2007 | 657 | 0.070 |
Why?
| Base Sequence | 1 | 2006 | 719 | 0.060 |
Why?
| Bone Morphogenetic Proteins | 1 | 2005 | 64 | 0.060 |
Why?
| Lung | 2 | 2023 | 507 | 0.060 |
Why?
| Molecular Sequence Data | 1 | 2006 | 980 | 0.060 |
Why?
| Mice, Obese | 1 | 2023 | 22 | 0.060 |
Why?
| Tomography | 1 | 2023 | 5 | 0.060 |
Why?
| Dinoprostone | 1 | 2023 | 55 | 0.060 |
Why?
| Cyclooxygenase 2 | 1 | 2023 | 49 | 0.060 |
Why?
| Multienzyme Complexes | 1 | 2003 | 41 | 0.060 |
Why?
| Electric Impedance | 1 | 2023 | 43 | 0.060 |
Why?
| Ubiquitination | 1 | 2023 | 47 | 0.060 |
Why?
| Biomimetics | 1 | 2023 | 4 | 0.060 |
Why?
| DNA | 1 | 2007 | 581 | 0.060 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 75 | 0.060 |
Why?
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2023 | 16 | 0.060 |
Why?
| Tissue Scaffolds | 1 | 2023 | 27 | 0.060 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2023 | 99 | 0.060 |
Why?
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2022 | 6 | 0.060 |
Why?
| Skin | 1 | 2006 | 469 | 0.060 |
Why?
| Positive-Pressure Respiration | 1 | 2023 | 61 | 0.060 |
Why?
| Biocompatible Materials | 1 | 2023 | 65 | 0.060 |
Why?
| AMP-Activated Protein Kinases | 1 | 2022 | 29 | 0.060 |
Why?
| Injections, Intra-Articular | 1 | 2022 | 34 | 0.060 |
Why?
| Artificial Intelligence | 1 | 2024 | 85 | 0.060 |
Why?
| Phenethylamines | 1 | 2022 | 10 | 0.060 |
Why?
| Liver | 1 | 2009 | 1225 | 0.060 |
Why?
| Mice, Nude | 1 | 2023 | 283 | 0.050 |
Why?
| Extracellular Matrix | 1 | 2023 | 111 | 0.050 |
Why?
| Hospitals | 1 | 2024 | 188 | 0.050 |
Why?
| Cell Respiration | 1 | 2022 | 51 | 0.050 |
Why?
| Calcification, Physiologic | 1 | 2022 | 42 | 0.050 |
Why?
| Sirtuin 3 | 1 | 2022 | 17 | 0.050 |
Why?
| Fibrosis | 1 | 2022 | 208 | 0.050 |
Why?
| Transplantation, Heterologous | 1 | 2021 | 77 | 0.050 |
Why?
| Collagen | 1 | 2023 | 223 | 0.050 |
Why?
| Primates | 1 | 2021 | 20 | 0.050 |
Why?
| Organ Size | 1 | 2022 | 237 | 0.050 |
Why?
| Ultrasonography, Interventional | 1 | 2022 | 146 | 0.050 |
Why?
| Macaca mulatta | 1 | 2021 | 106 | 0.050 |
Why?
| Blood Platelets | 1 | 2023 | 269 | 0.050 |
Why?
| Sulfonamides | 1 | 2022 | 146 | 0.050 |
Why?
| Sensitivity and Specificity | 1 | 2023 | 923 | 0.050 |
Why?
| Retrospective Studies | 2 | 2023 | 6432 | 0.050 |
Why?
| Neoplasm Proteins | 1 | 2003 | 359 | 0.050 |
Why?
| Nitric Oxide Synthase | 2 | 2010 | 102 | 0.050 |
Why?
| Swine | 1 | 2021 | 431 | 0.050 |
Why?
| Postoperative Complications | 2 | 2023 | 1033 | 0.050 |
Why?
| Cisplatin | 1 | 2022 | 352 | 0.050 |
Why?
| Diagnosis, Differential | 1 | 2023 | 1136 | 0.040 |
Why?
| Honduras | 1 | 2019 | 2 | 0.040 |
Why?
| Spouses | 1 | 2019 | 14 | 0.040 |
Why?
| Pain | 1 | 2022 | 405 | 0.040 |
Why?
| Molecular Structure | 1 | 2020 | 319 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2020 | 423 | 0.040 |
Why?
| Risk Reduction Behavior | 1 | 2019 | 70 | 0.040 |
Why?
| Intention | 1 | 2019 | 44 | 0.040 |
Why?
| Preventive Health Services | 1 | 2019 | 53 | 0.040 |
Why?
| Sexual Behavior | 1 | 2019 | 126 | 0.040 |
Why?
| Mice, Transgenic | 2 | 2013 | 656 | 0.040 |
Why?
| Endothelial Cells | 2 | 2010 | 294 | 0.040 |
Why?
| Disease Models, Animal | 1 | 2023 | 1639 | 0.040 |
Why?
| Skull | 2 | 2009 | 79 | 0.040 |
Why?
| Prognosis | 1 | 2022 | 2118 | 0.040 |
Why?
| Kidney | 1 | 2022 | 820 | 0.040 |
Why?
| Socioeconomic Factors | 1 | 2019 | 642 | 0.040 |
Why?
| Fibroblasts | 2 | 2009 | 386 | 0.040 |
Why?
| Logistic Models | 1 | 2019 | 995 | 0.030 |
Why?
| Calcium | 2 | 2011 | 432 | 0.030 |
Why?
| Transcription, Genetic | 2 | 2010 | 418 | 0.030 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 673 | 0.030 |
Why?
| Olivary Nucleus | 1 | 2015 | 8 | 0.030 |
Why?
| Cochlea | 1 | 2015 | 20 | 0.030 |
Why?
| Phonetics | 1 | 2014 | 49 | 0.030 |
Why?
| China | 1 | 2014 | 104 | 0.030 |
Why?
| Adoptive Transfer | 1 | 2014 | 38 | 0.030 |
Why?
| Cross-Sectional Studies | 1 | 2019 | 1693 | 0.030 |
Why?
| Gene Order | 1 | 2013 | 18 | 0.030 |
Why?
| Absorption | 1 | 2013 | 24 | 0.030 |
Why?
| Carbocyanines | 1 | 2013 | 8 | 0.030 |
Why?
| Leukocyte Count | 1 | 2013 | 77 | 0.030 |
Why?
| Gene Targeting | 1 | 2013 | 32 | 0.030 |
Why?
| Carcinoma, Lewis Lung | 1 | 2013 | 11 | 0.030 |
Why?
| Intracellular Space | 1 | 2013 | 31 | 0.030 |
Why?
| Telomerase | 1 | 2013 | 30 | 0.030 |
Why?
| Caco-2 Cells | 1 | 2013 | 50 | 0.030 |
Why?
| Sequence Analysis, RNA | 1 | 2013 | 107 | 0.030 |
Why?
| Permeability | 1 | 2013 | 87 | 0.030 |
Why?
| Endocytosis | 1 | 2013 | 60 | 0.030 |
Why?
| Gene Silencing | 1 | 2013 | 129 | 0.030 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2013 | 219 | 0.030 |
Why?
| Cell Death | 1 | 2013 | 223 | 0.030 |
Why?
| Mice, 129 Strain | 1 | 2011 | 49 | 0.030 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 474 | 0.030 |
Why?
| United States | 1 | 2023 | 5217 | 0.030 |
Why?
| Pregnancy | 1 | 2019 | 2620 | 0.030 |
Why?
| Internet | 1 | 2013 | 275 | 0.020 |
Why?
| Femur | 1 | 2011 | 144 | 0.020 |
Why?
| GTP Cyclohydrolase | 1 | 2010 | 5 | 0.020 |
Why?
| Colony-Forming Units Assay | 1 | 2010 | 31 | 0.020 |
Why?
| Case-Control Studies | 1 | 2014 | 1228 | 0.020 |
Why?
| Phenotype | 1 | 2014 | 820 | 0.020 |
Why?
| Vesicular Glutamate Transport Protein 2 | 1 | 2010 | 8 | 0.020 |
Why?
| Vascular System Injuries | 1 | 2010 | 37 | 0.020 |
Why?
| Drug Synergism | 1 | 2010 | 171 | 0.020 |
Why?
| Biological Availability | 1 | 2010 | 131 | 0.020 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 37 | 0.020 |
Why?
| Deoxyguanosine | 1 | 2010 | 32 | 0.020 |
Why?
| Malondialdehyde | 1 | 2010 | 63 | 0.020 |
Why?
| Bone Marrow Cells | 1 | 2010 | 233 | 0.020 |
Why?
| Core Binding Factor beta Subunit | 1 | 2009 | 4 | 0.020 |
Why?
| Embryo, Mammalian | 1 | 2009 | 68 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 74 | 0.020 |
Why?
| Imaging, Three-Dimensional | 1 | 2010 | 171 | 0.020 |
Why?
| Immunoblotting | 1 | 2009 | 134 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2013 | 1550 | 0.020 |
Why?
| Stromal Cells | 1 | 2009 | 79 | 0.020 |
Why?
| Survival Analysis | 1 | 2010 | 735 | 0.020 |
Why?
| Analysis of Variance | 1 | 2010 | 635 | 0.020 |
Why?
| Microarray Analysis | 1 | 2008 | 84 | 0.020 |
Why?
| Muscle, Smooth | 1 | 2008 | 68 | 0.020 |
Why?
| Vitamin D | 1 | 2009 | 101 | 0.020 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2010 | 250 | 0.020 |
Why?
| Lymphoid Tissue | 1 | 2007 | 23 | 0.020 |
Why?
| Receptors, Thrombin | 1 | 2007 | 16 | 0.020 |
Why?
| Thrombin | 1 | 2007 | 49 | 0.020 |
Why?
| Protein C | 1 | 2007 | 23 | 0.020 |
Why?
| Survival Rate | 1 | 2010 | 951 | 0.020 |
Why?
| Abdominal Neoplasms | 1 | 2007 | 19 | 0.020 |
Why?
| Pelvic Neoplasms | 1 | 2007 | 20 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2008 | 531 | 0.020 |
Why?
| Drug Evaluation, Preclinical | 1 | 2007 | 158 | 0.020 |
Why?
| Gastrointestinal Tract | 1 | 2007 | 135 | 0.020 |
Why?
| Injections | 1 | 2005 | 61 | 0.020 |
Why?
| Histocytochemistry | 1 | 2005 | 46 | 0.020 |
Why?
| Blotting, Northern | 1 | 2005 | 108 | 0.020 |
Why?
| Genetic Markers | 1 | 2005 | 117 | 0.020 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 122 | 0.020 |
Why?
| Glycoproteins | 1 | 2005 | 132 | 0.020 |
Why?
| Absorptiometry, Photon | 1 | 2005 | 174 | 0.020 |
Why?
| Cell Division | 1 | 2005 | 330 | 0.020 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 208 | 0.020 |
Why?
| Lumbar Vertebrae | 1 | 2005 | 105 | 0.020 |
Why?
| bcl-Associated Death Protein | 1 | 2003 | 13 | 0.010 |
Why?
| Antineoplastic Agents | 1 | 2013 | 1300 | 0.010 |
Why?
| Dactinomycin | 1 | 2003 | 23 | 0.010 |
Why?
| Culture Media, Conditioned | 1 | 2003 | 52 | 0.010 |
Why?
| Incidence | 1 | 2007 | 1082 | 0.010 |
Why?
| Bone and Bones | 1 | 2007 | 516 | 0.010 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 56 | 0.010 |
Why?
| Models, Genetic | 1 | 2003 | 209 | 0.010 |
Why?
| HeLa Cells | 1 | 2003 | 291 | 0.010 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 131 | 0.010 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 158 | 0.010 |
Why?
| RNA | 1 | 2003 | 202 | 0.010 |
Why?
| Kinetics | 1 | 2003 | 692 | 0.010 |
Why?
| Phosphorylation | 1 | 2003 | 614 | 0.010 |
Why?
| Child | 1 | 2014 | 7341 | 0.010 |
Why?
| Quality of Life | 1 | 2007 | 922 | 0.010 |
Why?
| Risk Factors | 1 | 2006 | 3935 | 0.010 |
Why?
|
|
Fu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|